UniQure - busy April

Sangamo....... not so much.

uniQure Announces Presentations at Upcoming April Conferences

LEXINGTON, Mass. and AMSTERDAM, the Netherlands, April 03, 2017 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced presentations at the following conferences taking place in April:

World Orphan Drug Congress USA, April 19 - 21 2017, at the Washington Marriott Wardman Park in Washington D.C.

• Matt Kapusta, Chief Executive Officer, will be presenting a keynote address: Adeno-associated virus (AAV)-based gene therapies for rare, chronic and degenerative diseases, on Friday April 21st, 2017, 9.40 a.m. EDT.

12th Annual HD Therapeutics Conference by CHDI, April 24 - 27 2017, at the Westin Dragonara Resort in St. Julian's, Malta.

• A presentation new preclinical data on huntingtin gene silencing in a mini-pig model of Huntington's Disease, using allele-specific and non-selective miRNAs, will be presented during the CHDI conference.

Gene Therapy for Rare Disorders Conference, April 25 - 26 2017, at the Sheraton Boston Hotel, in Boston MA.

• Lance Weed, Vice President of US Operations, will be presenting: Optimizing the Scalability of Gene Therapy Manufacturing, on Tuesday April 25th, 2017, 2.00 p.m. EDT.
• Eileen Sawyer, Director of Global Medical Affairs, will be presenting: Bridging Gaps Through Early Integration of the Internal Medical Affairs Function, on Wednesday April 26th, 2017, 11.00 a.m. EDT.
• Daniel Leonard, Director of Global Patient Advocacy, will be presenting: The Intersection of Patient Advocacy and Gene Therapy: A Case Study in Hemophilia, on Wednesday April 26th, 2017, 2.00 p.m. EDT.

Alliance for Regenerative Medicines (ARM)'s 5th Annual Cell & Gene Therapy Investor Day, April 27th 2017, at The State Room, in Boston MA.

• Matthew Kapusta, chief executive officer, will be participating in a fireside chat on Thursday, April 27th, 2017, 2.15 p.m. EDT.

The Company also announced its participation in the following conferences taking place in April:

Hemophilia Federation of America (HFA)'s Annual Symposium, April 6 - 9 2017, at the Rhode Island Convention Center in Providence, RI.

The International Liver Congress 2017 by EASL, April 19 - 23 2017 at the RAI in Amsterdam, The Netherlands.